Cardiovascular effects of drugs used to treat Alzheimer's disease.
about
Natural Phytochemicals in the Treatment and Prevention of Dementia: An OverviewLong-term efficacy and toxicity of cholinesterase inhibitors in the treatment of Alzheimer disease.Distribution of intravenously administered acetylcholinesterase inhibitor and acetylcholinesterase activity in the adrenal gland: 11C-donepezil PET study in the normal ratIntermittent hypoxia training protects cerebrovascular function in Alzheimer's disease.Sodium Tanshinone IIA Sulfonate Attenuates Scopolamine-Induced Cognitive Dysfunctions via Improving Cholinergic SystemEfficacy of memantine hydrochloride once-daily in Alzheimer's disease.Dementia in older people: an update.Benefits and risks of add-on therapies for Alzheimer's disease.MODULATION OF N-METHYL-D-ASPARTATE RECEPTORS IN ISOLATED RAT HEART.Acetylcholinesterase inhibitors for treating dementia symptoms - a safety evaluation.Association of Antidementia Drugs and Mortality in Community-Dwelling Frail Older Patients With Dementia: The Role of Mortality Risk Assessment.Withdrawal of Antidementia Drugs in Older People: Who, When and How?Acetylcholinesterase Inhibition Attenuates the Development of Hypertension and Inflammation in Spontaneously Hypertensive Rats.Ameliorative effect of kolaviron, a biflavonoid complex from Garcinia kola seeds against scopolamine-induced memory impairment in rats: role of antioxidant defense system.Acetylcholinesterase Inhibitors: Beneficial Effects on Comorbidities in Patients With Alzheimer's Disease.Electrocardiogram Changes of Donepezil Administration in Elderly Patients with Ischemic Heart Disease.
P2860
Q26750581-E2D0B985-7AF9-4CE7-9C4F-807AA7C565B2Q35006354-D8307A83-4C4C-4D4F-924A-A56FF9531FAAQ35254862-96CEFCF6-6D83-49E9-AA7C-A66161C080EFQ37106933-E92E037F-179F-4430-81FB-B500CA4459FDQ37172017-6997CB38-048C-4DAC-AEE3-6B96349A6CF6Q38236190-96034D56-E0A1-4613-A8FC-C3442EFEB5F2Q38264846-23332AD5-DF72-487C-A768-F9EFA5AF263DQ38620338-6FDAAD93-5F34-444E-BA1E-2A7108D10D53Q38652337-CE51A6C6-3797-46BA-B2D3-05CF5047E513Q39415447-5BA235F6-08E7-4A34-AA43-D65C81B471A4Q47444669-389FBE9A-9750-4860-A95F-9EE4C53C170DQ48167336-902777C3-DDC1-47C6-9170-B8B298973255Q48287214-72381591-8FFE-4F4A-90C9-EEAB16A7AEC9Q48511914-7AB461E0-C210-42A2-B0AB-91B86ACBCBDAQ49645966-9ADF2C2A-AE71-4D53-ADC6-BFC15B5134C3Q55231435-5A50D4AA-F289-4E59-B682-5C45F2CFA7CF
P2860
Cardiovascular effects of drugs used to treat Alzheimer's disease.
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունիսին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունիսին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@ast
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@en
type
label
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@ast
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@en
prefLabel
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@ast
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@en
P2860
P1433
P1476
Cardiovascular effects of drugs used to treat Alzheimer's disease.
@en
P2093
Laurence Guy Howes
P2860
P2888
P304
P356
10.1007/S40264-014-0161-Z
P577
2014-06-01T00:00:00Z
P6179
1047559870